Get the Stockscreener App
43.74
2.60%
1.11
After Hours:
43.51
-0.23
-0.53%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $43.74, with a volume of 733.08K.
It is up +2.60% in the last 24 hours and up +27.00% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
See More
Previous Close:
$42.63
Open:
$42.77
24h Volume:
733.08K
Relative Volume:
0.71
Market Cap:
$2.33B
Revenue:
$225.21M
Net Income/Loss:
$-15.70M
P/E Ratio:
-129.18
EPS:
-0.3386
Net Cash Flow:
$-4.78M
1W Performance:
+4.17%
1M Performance:
+27.00%
6M Performance:
+87.08%
1Y Performance:
+161.13%
1-Day Range:
$41.75
$43.80
1-Week Range:
$40.34
$43.80
52-Week Range:
$9.215
$45.83
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
43.74 | 2.27B | 225.21M | -15.70M | -4.78M | -0.3386 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Wells Fargo | Overweight |
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen outlines at least $270M 2026 revenue on at least 20% growth amid Avance biologic channel transition - MSN
Axogen (AXGN) Is Up 10.3% After Raising 2026 Revenue Outlook Despite Wider Q1 Loss – Has The Bull Case Changed? - simplywall.st
Axogen (AXGN) Q1 2025 Earnings Transcript - AOL.com
AxoGen (NASDAQ:AXGN) Cut to "Hold" at Wall Street Zen - MarketBeat
Axogen, Inc. (NASDAQ:AXGN) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Axogen (AXGN) Q1 2026 Deep Dive: $0.07 EPS, Revenue Up 27% - AlphaStreet
Nerve Repair And Regenerative Market Set to Boom Rapidly, - openPR.com
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference - The Manila Times
Axogen, Inc. (NASDAQ:AXGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$50.78 - simplywall.st
Axogen executives take Bank of America healthcare stage May 13 - Stock Titan
AxoGen Reports Third Quarter 2025 Financial Results and Growth - HarianBasis.co
AXGN Maintained by Canaccord Genuity -- Price Target Raised to $50 - GuruFocus
Vanguard reports 2.66M Axogen stake (NASDAQ: AXGN) - Stock Titan
[ARS] Axogen, Inc. SEC Filing - Stock Titan
FDA win and 20% growth frame Axogen (NASDAQ: AXGN) 2026 pay vote - Stock Titan
AXGN Maintained by Citizens -- Price Target Raised to $50.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
AXGN Maintained by Wells Fargo -- Price Target Raised to $38.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Price Target Raised to $48.00 at Wells Fargo & Company - MarketBeat
Axogen Q1 2026 revenue up 26.6% to USD 61.5M - Medical Buyer
Citizens raises AxoGen stock price target to $50 on strong sales - Investing.com Australia
AXGN Maintained by HC Wainwright & Co. -- Price Target Raised to $50 - GuruFocus
H.C. Wainwright raises AxoGen stock price target to $50 on revenue beat - Investing.com Nigeria
H.C. Wainwright raises AxoGen stock price target to $50 on revenue beat By Investing.com - Investing.com South Africa
Mizuho raises AxoGen stock price target to $55 on strong growth By Investing.com - Investing.com South Africa
AxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook - The Globe and Mail
Mizuho raises AxoGen stock price target to $55 on strong growth - Investing.com Australia
AxoGen (NASDAQ:AXGN) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Citizens raises AxoGen stock price target to $50 on strong sales By Investing.com - Investing.com South Africa
AxoGen Q1 2026 slides: 27% revenue surge drives stock rally By Investing.com - Investing.com Australia
Axogen Inc (AXGN) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
Axogen Inc (AXGN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses By GuruFocus - Investing.com Canada
Axogen Inc stock hits 52-week high at 42.32 USD By Investing.com - Investing.com South Africa
Axogen (NASDAQ: AXGN) lifts Q1 revenue 26.6% while fully repaying credit facility - Stock Titan
Axogen (AXGN) Q3 2025 Earnings Transcript - AOL.com
AxoGen Stock Rockets 12% on Q1 2026 Revenue Beat, Raised Guidance and Debt-Free Balance Sheet - International Business Times
Axogen Releases Q1 2026 Financial Results - AlphaStreet
AxoGen, aziende energetiche, Corning - TradingView
AxoGen (AXGN) Q1 earnings lag estimates - MSN
AxoGen Q1 2026 Earnings Call Transcript - MarketBeat
AxoGen (NASDAQ:AXGN) Hits New 1-Year HighHere's Why - MarketBeat
AxoGen (AXGN) Shares Surge 12.8% - GuruFocus
AXGN Stock Climbs As Analysts Hike Price Targets On Coverage Wins - timothysykes.com
Do options traders know something about Axogen stock we don't? - MSN
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):